Small Product, Big Innovation
Congratulations to iMFLUX and Procter & Gamble on developing a nasal swab so innovative that it was recently awarded US Design Patent D942,000. The nasal swab will improve the speed of COVID-19 testing and help ease testing supply issues.
P&G’s Personal Health care team collaborated with iMFLUX to develop a novel fully injection-molded polypropylene nasal swab — so healthcare workers can collect samples from the front of the nose rather than through the long cavity between the nose and the mouth. Rhinostics, a Harvard University spin-off company, has licensed the swab and is pursuing Emergency Use Authorization for home collection testing for COVID-19. To read the full P&G press release, click here.
Marshall Gerstein is proud to have worked on the US Design Patent for the new nasal swab. To see the full issued patent, click here.
